SCLX Q2 2022 Earnings — Scilex Holding Company Revenue & Financial Results | Market Cap Arena

SCLXScilex Holding Company

$73M

Q2 2022 Earnings

Healthcare Drug Manufacturers - General

Income Statement

Revenue

$8M-14.0% YoY

Gross Profit

$6M80.7% margin

Operating Income

-$11M-144.7% margin

Net Income

-$18M-225.1% margin

EPS (Diluted)

$-0.13

QoQ Revenue Growth

+16.4%

Cash Flow

Operating Cash Flow

-$12M

Free Cash Flow

-$12M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$90M

Total Liabilities

$342M

Stockholders' Equity

-$252M

Cash & Equivalents

$7M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8M	$9M	-14.0%
Gross Profit	$6M	$9M	-26.4%
Operating Income	-$11M	-$7M	-70.4%
Net Income	-$18M	-$15M	-16.0%